In general, children have lower incidences of SARS-CoV-2 infection, severe dz, & death compared w/ adults. Risk factors for severe dz include presence of ≥1 severe comorbidity such as medical complexity w/ respiratory technology dependence, neurologic condition resulting in impaired mucociliary clearance, obesity (esp severe obesity), severe underlying cardiac or pulmonary dz, & severe immunocompromise.
Generally, the older the child & the more severe the dz, the more reasonable it is to follow tx recs for adult pts w/ COVID-19.
No drug is authorized or approved for pre-exposure prophylaxis of COVID-19. CDC recommends that everyone ≥6 mo of age stay up-to-date w/ COVID-19 vaccination, including boosters, if eligible.
Consensus Guidelines for COVID-19 Drug Therapies in Adults
Guideline | Resources |
NIH Guidelines for COVID-19 Drug Therapies in Children |
Key Points
Choose Patient Type
|
NIH. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.
[
2023 Guideline
]
Epocrates Guideline Synopsis Last Update:
Oct 4, 2023
Publication Year:
2023
Source:
epocrates
Abbreviations
CAA | coronary artery aneurysm |
ECMO | extracorporeal membrane oxygenation |
IDSA | Infectious Diseases Society of America |
NIH | National Institutes of Health |
WHO | World Health Organization |